Healthcare provider profile · identity verified

Daniel M Palmquist, M.D.

Family Practice · CLOQUET, MN · NPI 1932281201

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	515	109
Lisinopril	Lisinopril	510	126
Atorvastatin Calcium	Atorvastatin Calcium	500	120
Losartan Potassium	Losartan Potassium	465	106
Tamsulosin Hcl	Tamsulosin Hcl	374	90
Amlodipine Besylate	Amlodipine Besylate	366	88
Levothyroxine Sodium	Levothyroxine Sodium	356	64
Metoprolol Succinate	Metoprolol Succinate	315	76
Metformin Hcl	Metformin Hcl	279	70
Gabapentin	Gabapentin	237	43
Simvastatin	Simvastatin	235	56
Sertraline Hcl	Sertraline Hcl	234	58
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	203	34
Allopurinol	Allopurinol	201	49
Finasteride	Finasteride	186	38
Metoprolol Tartrate	Metoprolol Tartrate	182	39
Furosemide	Furosemide	174	39
Rosuvastatin Calcium	Rosuvastatin Calcium	170	42
Hydrochlorothiazide	Hydrochlorothiazide	161	36
Tramadol Hcl	Tramadol Hcl	156	24
Zolpidem Tartrate	Zolpidem Tartrate	135	21
Lorazepam	Lorazepam	132	23
Xarelto	Rivaroxaban	122	22
Albuterol Sulfate Hfa	Albuterol Sulfate	116	32
Warfarin Sodium	Warfarin Sodium	110	24
Citalopram Hbr	Citalopram Hydrobromide	100	18
Metformin Hcl Er	Metformin Hcl	95	27
Eliquis	Apixaban	93	19
Pravastatin Sodium	Pravastatin Sodium	91	23
Trazodone Hcl	Trazodone Hcl	90	17
Potassium Chloride	Potassium Chloride	81	17
Fluoxetine Hcl	Fluoxetine Hcl	79	15
Donepezil Hcl	Donepezil Hcl	77	12
Alprazolam	Alprazolam	76	suppressed
Pregabalin	Pregabalin	76	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	75	15
Shingrix	Varicella-Zoster Ge/As01b/Pf	75	66
Glimepiride	Glimepiride	74	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	15
Clonazepam	Clonazepam	72	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	71	71
Atenolol	Atenolol	71	22
Prednisone	Prednisone	69	41
Azithromycin	Azithromycin	68	57
Pantoprazole Sodium	Pantoprazole Sodium	66	16
Montelukast Sodium	Montelukast Sodium	62	14
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	61	61
Torsemide	Torsemide	61	15
Morphine Sulfate Er	Morphine Sulfate	60	suppressed
Clopidogrel	Clopidogrel Bisulfate	59	14
Ondansetron Hcl	Ondansetron Hcl	58	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	12
Mirtazapine	Mirtazapine	53	suppressed
Alendronate Sodium	Alendronate Sodium	51	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	11
Ozempic	Semaglutide	47	suppressed
Celecoxib	Celecoxib	46	14
Gemfibrozil	Gemfibrozil	46	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	suppressed
Buspirone Hcl	Buspirone Hcl	41	suppressed
Ezetimibe	Ezetimibe	41	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	suppressed
Risperidone	Risperidone	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	11
Duloxetine Hcl	Duloxetine Hcl	36	11
Triamcinolone Acetonide	Triamcinolone Acetonide	35	23
Nystatin	Nystatin	34	16
Doxycycline Hyclate	Doxycycline Hyclate	33	22
Propranolol Hcl	Propranolol Hcl	33	suppressed
Baclofen	Baclofen	32	14
Levetiracetam	Levetiracetam	32	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Ventolin Hfa	Albuterol Sulfate	31	12
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Trintellix	Vortioxetine Hydrobromide	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	29	suppressed
Jardiance	Empagliflozin	29	suppressed
Aripiprazole	Aripiprazole	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Naproxen	Naproxen	26	suppressed
Carvedilol	Carvedilol	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	12
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	19
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Rybelsus	Semaglutide	20	suppressed
Morphine Sulfate	Morphine Sulfate	19	suppressed
Digoxin	Digoxin	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Famotidine	Famotidine	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Ramipril	Ramipril	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Ciclopirox	Ciclopirox	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Trimethoprim	Trimethoprim	17	suppressed
Unifine Pentips	Pen Needle, Diabetic	17	suppressed
Nitroglycerin	Nitroglycerin	16	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Insulin Aspart Flexpen	Insulin Aspart	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Cephalexin	Cephalexin	13	11
Farxiga	Dapagliflozin Propanediol	13	suppressed
Invokana	Canagliflozin	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Armour Thyroid	Thyroid,pork	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Lithium Carbonate Er	Lithium Carbonate	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Dofetilide	Dofetilide	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Lurasidone Hcl	Lurasidone Hcl	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Yuvafem	Estradiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error